Literature DB >> 21806492

Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing.

Melissa V Chan1, Paul C J Armstrong, Francesco Papalia, Nicholas S Kirkby, Timothy D Warner.   

Abstract

Platelet reactivity testing is important for the diagnosis of bleeding disorders, and increasingly to optimise anti-platelet therapy. Traditional light transmission aggregometry is considered the gold standard, whilst 96-well plate aggregometry, founded on similar principles, provides a higher throughput screening method. Despite the widespread use of both, methodologies and outputs vary widely between laboratories. We report a methodological approach towards providing a standardised optical detection of platelet aggregation (optimul method) based upon 96-well plate aggregometry. Individual wells of half-area 96-well plates were coated with gelatine and one of seven concentrations of arachidonic acid (AA), adenosine diphosphate (ADP), collagen, epinephrine (EPI), ristocetin, TRAP-6 amide or U46619, before being lyophilised, vacuum-sealed, foil-packed and stored at room temperature for up to 24 weeks. For platelet testing, 40 µl of platelet-rich plasma was added to each well. Platelet aggregation was determined by changes in light absorbance, release of ATP/ADP by luminescence and release of thromboxane (TX) A(2) by ELISA. Some experiments were conducted in the presence of aspirin (30 µM) or prasugrel active metabolite (PAM; 3 µM). Optimul plates stored for up to 12 weeks permitted reliable detection of concentration-dependent platelet aggregation, ATP/ADP release and TXA₂ production. PAM caused reductions in platelet responses to AA, ADP, collagen, EPI, TRAP-6 and U46619, whilst aspirin inhibited responses to AA, collagen and EPI. We conclude that the optimul method offers a viable, standardised approach, allowing platelet reactivity testing and could provide a broad platelet function analysis without the need for dedicated equipment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21806492     DOI: 10.3109/09537104.2011.592958

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  14 in total

1.  Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients.

Authors:  Paul Vulliamy; Samantha J Montague; Scarlett Gillespie; Melissa V Chan; Lucy A Coupland; Robert K Andrews; Timothy D Warner; Elizabeth E Gardiner; Karim Brohi; Paul C Armstrong
Journal:  Blood Adv       Date:  2020-06-23

2.  Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide.

Authors:  Nicholas S Kirkby; Martina H Lundberg; Melissa V Chan; Ivana Vojnovic; Antonia B Solomon; Michael Emerson; Jane A Mitchell; Timothy D Warner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

3.  Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1.

Authors:  Francesca Rauzi; Nicholas S Kirkby; Matthew L Edin; James Whiteford; Darryl C Zeldin; Jane A Mitchell; Timothy D Warner
Journal:  FASEB J       Date:  2016-09-15       Impact factor: 5.191

4.  The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects.

Authors:  Alexander R Stainer; Parvathy Sasikumar; Alexander P Bye; Amanda J Unsworth; Lisa M Holbrook; Marcus Tindall; Julie A Lovegrove; Jonathan M Gibbins
Journal:  TH Open       Date:  2019-07-30

5.  Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction.

Authors:  Paul C J Armstrong; Nicholas S Kirkby; Melissa V Chan; Michaela Finsterbusch; Nancy Hogg; Sussan Nourshargh; Timothy D Warner
Journal:  Blood       Date:  2015-07-27       Impact factor: 22.113

6.  Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay.

Authors:  Marie Lordkipanidzé; Gillian C Lowe; Nicholas S Kirkby; Melissa V Chan; Martina H Lundberg; Neil V Morgan; Danai Bem; Shaista P Nisar; Vincenzo C Leo; Matthew L Jones; Stuart J Mundell; Martina E Daly; Andrew D Mumford; Timothy D Warner; Steve P Watson
Journal:  Blood       Date:  2014-01-09       Impact factor: 22.113

7.  Light transmission aggregometry using pre-coated microtiter plates and a Victor X5 plate reader.

Authors:  Pernille Just Vinholt; Mads Nybo; Camilla Brødsgaard Nielsen; Anne-Mette Hvas
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

8.  Identification of a New Morpholine Scaffold as a P2Y12 Receptor Antagonist.

Authors:  Young Ha Ahn; Joo-Youn Lee; Hee Dong Park; Tae Hun Kim; Min Chul Park; Gildon Choi; Sunghoon Kim
Journal:  Molecules       Date:  2016-08-24       Impact factor: 4.411

9.  Not all light transmission aggregation assays are created equal: qualitative differences between light transmission and 96-well plate aggregometry.

Authors:  Melissa V Chan; Philip D Leadbeater; Steve P Watson; Timothy D Warner
Journal:  Platelets       Date:  2018-05-01       Impact factor: 3.862

Review 10.  96-well plate-based aggregometry.

Authors:  Melissa V Chan; Paul C Armstrong; Timothy D Warner
Journal:  Platelets       Date:  2018-03-15       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.